Paneth cell hyperplasia and metaplasia in necrotizing enterocolitis
Related Experiment Video
Updated: Jun 3, 2026

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis
Published on: June 8, 2022
Patrycja J Puiman1, Nanda Burger-Van Paassen, Maaike W Schaart
1Department of Neonatology, Erasmus MC-Sophia Children's Hospital, Rotterdam 3015 GJ, The Netherlands.
Insights
Paneth cells in necrotizing enterocolitis (NEC) show hyperplasia and increased defensin production after recovery, suggesting a crucial role in NEC pathogenesis and defense against bacteria.
Area of Science:
- Gastroenterology
- Neonatal Research
- Immunology
Background:
- Necrotizing enterocolitis (NEC) is a severe intestinal disease in preterm infants.
- Paneth cell dysfunction is implicated in NEC pathogenesis.
- Understanding Paneth cell behavior is crucial for NEC management.
Purpose of the Study:
- To investigate Paneth cell presence, protein expression, and developmental changes in NEC.
- To analyze Paneth cell products and antimicrobial function in ileostomy outflow fluid.
Main Methods:
- Immunohistochemistry on intestinal tissue from NEC patients and controls.
- RT-PCR for Paneth cell protein mRNA levels.
- Quantification of Paneth cell products and in vitro antimicrobial assays on ileostomy fluid.
Main Results:
- Paneth cell abundance was similar in acute NEC and preterm controls.
- Paneth cell hyperplasia and increased human alpha-defensin 5 mRNA were observed post-NEC recovery.
- Metaplastic Paneth cells appeared in the colon of NEC patients.
- Ileostomy fluid demonstrated antimicrobial activity against bacteria.
Conclusions:
- Paneth cells and their products play a significant role throughout NEC.
- Post-NEC recovery involves Paneth cell hyperplasia and enhanced antimicrobial defenses.
- Metaplastic Paneth cells in the colon may represent an adaptive response.
Abstract:
Paneth cell dysfunction has been suggested in necrotizing enterocolitis (NEC). The aim of this study was to i) study Paneth cell presence, protein expression, and developmental changes in preterm infants with NEC and ii) determine Paneth cell products and antimicrobial capacity in ileostomy outflow fluid. Intestinal tissue from NEC patients (n = 55), preterm control infants (n = 22), and term controls (n = 7) was obtained during surgical resection and at stoma closure after recovery. Paneth cell abundance and protein expression were analyzed by immunohistochemistry. RNA levels of Paneth cell proteins were determined by real-time quantitative RT-PCR. In ileostomy outflow fluid, Paneth cell products were quantified, and antimicrobial activity was measured in vitro. In acute NEC, Paneth cell abundance in small intestinal tissue was not significantly different from preterm controls. After recovery from NEC, Paneth cell hyperplasia was observed in the small intestine concomitant with elevated human alpha-defensin 5 mRNA levels. In the colon, metaplastic Paneth cells were observed. Ileostomy fluid contained Paneth cell proteins and inhibited bacterial growth. In conjunction, these data suggest an important role of Paneth cells and their products in various phases of NEC.
Related Concept Videos
Cellular Adaptation IV: Dysplasia and Metaplasia
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Renewal of Intestinal Stem Cells
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Cellular Adaptation III: Hyperplasia
